News
-
-
-
PRESS RELEASE
Press Release: Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicines
Rilzabrutinib granted orphan drug designation in the US for warm autoimmune hemolytic anemia and IgG4-related disease, potential use in immune thrombocytopenia. Sanofi's novel BTK inhibitor holds promise for rare diseases -
-
-
PRESS RELEASE
Ad hoc announcement pursuant to Art. 53 LR: Jungfraubahn Holding AG: Jungfrau Railway Group reports a successful 2024 financial year
Jungfraubahn Holding AG announces a successful 2024 financial year with increased transport income and proposal to raise dividend. Jungfraujoch and Experience Mountains segments show strong performance -
-
-
REGULATED PRESS RELEASE
Publication of the report on payments made to governments provided by article L.225-102-3 of the French Commercial Code
Compagnie de Saint-Gobain publishes report on payments made to governments in accordance with French Commercial Code article L. 232-6-2 for fiscal year 2024 -
